Pharma Pulse: A $7B Buyout, Tariff Refunds, Cold Chain Growth and More

Apr 23, 10:00 AM

Headliner
Share
Subscribe

In this week’s Pharma Pulse, GEODIS’ cold chain expansion in the Midwest, a potential multi-billion dollar shift in cell therapy, and the White House’s new push for psychedelic mental health treatments.

Share
Subscribe
Next
Pharma Pulse: Walgreens’ New Hybrid Pharmacist Model, Pharmacies Expand Injectable Access, and More
Top episodes
Overcoming Supply Chain Challenges
by Pharmaceutical Commerce
Incorporating AI into Commercialization Plans
by Pharmaceutical Commerce
The Capabilities of a 3PL Provider
by Pharmaceutical Commerce